![Similar Pharmacokinetics of the Adalimumab (Humira®) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe (VOLTAIRE®-AI and VOLTAIRE®-TAI): Phase 1, Randomized, Open-Label, Parallel-Group Trials | SpringerLink Similar Pharmacokinetics of the Adalimumab (Humira®) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe (VOLTAIRE®-AI and VOLTAIRE®-TAI): Phase 1, Randomized, Open-Label, Parallel-Group Trials | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40744-018-0119-1/MediaObjects/40744_2018_119_Fig1_HTML.png)
Similar Pharmacokinetics of the Adalimumab (Humira®) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe (VOLTAIRE®-AI and VOLTAIRE®-TAI): Phase 1, Randomized, Open-Label, Parallel-Group Trials | SpringerLink
INSTRUCTIONS FOR USE HUMIRA® (Hu-MARE-ah) (adalimumab) 40 MG/0.8 ML SINGLE-USE PEN Do not try to inject HUMIRA yourself until y
![Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analyst | Fierce Pharma Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analyst | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1626100092/large.img_.png/large.img_.png?VersionId=ueWCCdg1mXY0Ao4AwX6mTOFsnazgVMLm)
Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analyst | Fierce Pharma
INSTRUCTIONS FOR USE HUMIRA® (Hu-MARE-ah) (adalimumab) 40 MG/0.8 ML SINGLE-USE PEN Do not try to inject HUMIRA yourself until y
![Frontiers | A Patients' Perspective Towards the Injection Devices for Humira® and Imraldi® in a Nationwide Switching Program Frontiers | A Patients' Perspective Towards the Injection Devices for Humira® and Imraldi® in a Nationwide Switching Program](https://www.frontiersin.org/files/Articles/799494/fmed-09-799494-HTML/image_m/fmed-09-799494-t001.jpg)